Viewing Study NCT01013766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:22 PM
Ignite Modification Date: 2026-02-03 @ 10:39 AM
Study NCT ID: NCT01013766
Status: COMPLETED
Last Update Posted: 2017-06-20
First Post: 2009-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T2DM View
None Tolerability View
None GSK1362885 View
None Pharmacodynamics View
None Safety View
None Pharmacokinetics View